Literature DB >> 6482486

Survival following resection for second and third primary lung cancers.

D J Mathisen, R J Jensik, L P Faber, C F Kittle.   

Abstract

The performance of sequential resections and the consideration of new lesions as second or third primary lung cancers remain controversial issues. Criteria to define these as new primary lesions depend upon a difference in histologic types, a prolonged interval between initial and second or third resections, and location in the contralateral lung or a different ipsilateral lobe. Ninety patients have undergone multiple resections for bronchogenic carcinoma from 1960 to December, 1983. There were 10 examples of synchronous lesions and the remaining 80 were metachronous with the longest interval between resections being 17 years, 4 months. The initial surgical procedure was pneumonectomy in 11, lobectomy in 43, sleeve lobectomy in eight, segmentectomy in 27, and carinal resection in one. At the second operation, the procedures were segmentectomy in 55, lobectomy in 11, completion lobectomy in six, and completion pneumonectomy in 15. Two patients had sternotomy with bilateral resections and one patient had a tracheal resection. At the third operation, the procedures were segmentectomy in seven, completion lobectomy in two, and completion pneumonectomy in two. In 20 patients undergoing the second procedure and three undergoing a third resection, a different cell type was identified. The perioperative mortality following the second operation was seven of 90 patients (8%) and there were no deaths in those patients undergoing three resections. The cumulative survival rate following second resection in 80 patients with metachronous tumors was 33% at 5 years and 20% at 10 years. These data support continued aggressive surgical approach to second and third primary lung cancers.

Entities:  

Mesh:

Year:  1984        PMID: 6482486

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Two lung masses with different responses to pemetrexed.

Authors:  Kwang Young Park; Jae Wook Jung; Seung Bum Nam; Ho Jin Lee; Hyo Seok Kim; Yoon Hee Choi; Jae Cheol Lee
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 2.884

3.  The IASLC lung cancer staging project proposal for the classification of lung cancers with multiple pulmonary sites of involvement: the first step toward finding optimal treatment.

Authors:  Samuel S Kim
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  [The effectiveness of standardized follow-up studies after resection of non-small cell bronchial carcinoma].

Authors:  H U Zieren; J M Müller; D Petermann; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1994

5.  Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases.

Authors:  Wei Sun; Yu Liu; Xiang-Yang Liu; Dong-Mei Lin; Ning Lv
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Surgical treatment of synchronous multiple primary lung cancers: a retrospective analysis of 122 patients.

Authors:  Ming Liu; Wenxin He; Jie Yang; Gening Jiang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

7.  Bilateral sleeve lobectomy for metachronous multiple primary lung cancer.

Authors:  Y Watanabe; H Kobayashi; S Murakami; S Sawa; M Shinagawa; T Iwa
Journal:  Jpn J Surg       Date:  1986-01

8.  Synchronous multiple lung cancers presenting as multifocal pure ground glass nodules: are whole-body positron emission tomography/computed tomography and brain enhanced magnetic resonance imaging necessary?

Authors:  Meng Li; Yuan Wan; Li Zhang; Li-Na Zhou; Zhuo Shi; Rui Zhang; Yan-Lei Hou; Ning Wu
Journal:  Transl Lung Cancer Res       Date:  2019-10

9.  Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.

Authors:  D Matsuzoe; T Hideshima; K Ohshima; K Kawahara; T Shirakusa; A Kimura
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Completion pneumonectomy for lung cancer treatment: early and long term outcomes.

Authors:  Peng Zhang; Chao Jiang; Wenxin He; Nan Song; Xiao Zhou; Gening Jiang
Journal:  J Cardiothorac Surg       Date:  2012-10-09       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.